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Little is known about the role of chemokines and their receptors interaction, which are
essential for recruitment of selective lymphocyte subsets during inflammation, in the
pathogenesis of idiopathic nonspecific interstitial pneumonia (NSIP). Recent studies have
revealed Th1 and Th2 cells preferentially employ the chemokine receptors, CXCR3 and
CCR4, respectively, in the process of accumulation into inflammatory sites. We evaluated
the CXCR3 and CCR4 expression on infiltrated lymphocytes in lung tissues of 12 NSIP cases
and 10 idiopathic pulmonary fibrosis (IPF) cases in our previous study. The number of CXCR3
positive lymphocytes of NSIP patients was significantly greater than that of IPF patients
(261.17145.1 vs. 64.9727.0, Po0.01). The number of CCR4 positive lymphocytes of NSIP
patients was significantly lower than that of IPF (9.578.3 vs.62.6726.9, Po0.01). The
CXCR3 to CCR4 ratio of NSIP patients was significantly greater than that of IPF patients
(47.9745.9 vs. 1.1170.40, Po0.01). The differences of CXCR3 positive, CCR4 positive
lymphocyte counts, and of CXCR3/CCR4 ratio between cellular and fibrosing NSIP were not
significant. These results suggest that a Th1 pattern of chemokine receptor expression
predominates in the lung interstitium of patients with NSIP but, in IPF patients, CCR4 might
be relatively predominant, in contrast to the finding in NSIP patients, and that Th1/Th2
balance might be an important factor in the pathogenesis of NSIP.
& 2006 Elsevier Ltd. All rights reserved.Elsevier Ltd. All rights reserved.
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CXCR3 and CCR4 in NSIP 1259Materials and methodsIntroduction
Idiopathic nonspecific interstitial pneumonia (NSIP) has
recently been defined by Katzenstein and Fiorelli, as a
histologic subtype of idiopathic interstitial pneumonia (IIP)
and is pathologically distinguished from idiopathic pulmon-
ary fibrosis (IPF) by temporal uniformity of interstitial
inflammation and/or fibrosis on histology.1,2 Clinically, the
distinctive features of NSIP are that most patients with NSIP
respond to immunosuppressive therapy and have a better
prognosis than those with IPF.3,4 Bronchoalveolar lavage
analysis shows that NSIP has an increased number of
lymphocytes, mainly T cells, when compared with that of
IPF, and the subset of CD8+ Tcells predominates over CD4+ T
cells.5 These findings indicate that T cell mediated inflam-
mation is a key role in the pathogenesis of NSIP.
Antigen recognition by T cells is indispensable for the
initiation of T cell-mediated inflammation and requires
interaction between T cells and antigen-presenting cells
(APC). Dendritic cells (DC) are a family of professional APC
and play a key role in the induction of antigen-specific T cell
response. We reported that DC and T cells may play
important roles in the pathogenesis of NSIP.6 Trafficking of
activated T cells into inflammatory sites is also a critical
process in the development of T cell-mediated inflammation
and is a tightly controlled process directed by multiple
molecules, in particular adhesion molecules and chemo-
kines.7,8 Recent studies have elucidated certain chemokines
and chemokine receptors are preferentially associated with
the selective in vitro recruitment of Th1 cells, such as
interferon (IFN)-inducible protein (IP-10) and monokine-
induced IFN-gamma (Mig) and their receptor CXCR3,9–13 or
Th2 cells such as monocyte-derived chemokine (MDC) and
eotaxin and their receptors CCR4 and CCR3.10,12,14–16
From the perspective of T cell-mediated inflammation in
NSIP, it seems very important to clarify the mechanisms of T
cell recruitment into the lung parenchyma. In this immuno-
histochemical study, we analyzed infiltrating lymphocytes
expressing CXCR3 or CCR4 in the lung parenchyma in
patients with NSIP compared to those with IPF.Table 1 Clinical findings of patients with idiopathic NSIP.
Patient Age (yr) Pathology WBC (/ml) CRP (mg
1 74 NSIP/C 5000 0.1
2 66 NSIP/C 7300 0
3 67 NSIP/C 10,900 4.7
4 69 NSIP/C 4600 0.1
5 73 NSIP/C 6600 0.04
6 74 NSIP/C 7300 0.1
7 62 NSIP/C 7300 0.4
8 60 NSIP/F 8600 4
9 52 NSIP/F 8300 0.6
10 67 NSIP/F 9700 0.1
11 76 NSIP/F 9600 24
12 74 NSIP/F 10,000 5.2
NSIP/C; cellular NSIP, NSIP/F; fibrosing NSIP.
WBC; white blood cell, CRP; C-reactive protein, LDH; lactic dehydroLung biopsy materials
The subjects included 12 patients with NSIP between March
1990 and June 2001 (Table 1). The tissue specimens were
obtained by video-assisted thoracic surgery (VATS) and the
diagnosis was made histopathologically. The lung biopsy
specimens from 10 patients with IPF described in our
previous study17 were also included for comparison. The
other diseases manifesting UIP pattern or NSIP pattern were
also excluded. All pathological specimens were analyzed by
lung pathologists according to the criteria described by
the American Thoracic Society, with attention to NSIP and
IPF.18 Twelve patients with NSIP consisted of 10 men and 2
women. The median age was 67.8 years ranging from 52 to
76 years. The cellular pattern was shown in 58% (7/12) of
patients and the fibrosing pattern was indicated in 42% (5/
12) of patients. Ten patients with IPF were all men. The
median age of those patients with IPF was 63.1 years ranging
from 50 to 74 years.Immunohistochemistry
The immunohistological staining was performed using a SS
MultiLink Detection Kit, HRP/DAB (BioGenex Laboratories,
San Ramon, CA). The lung biopsy specimens were fixed in
10% neutral buffered formalin solution, cut into slices,
embedded in paraffin and sectioned at 5 mm for histological
evaluation and immunochistochemical staining. Immunohis-
tological staining was performed using the streptavidin/
biotin/peroxidase complex method as previously de-
scribed.17 The antibodies used were for CXCR3 (clone 1C6,
BD Pharmingen, San Diego, CA) and CCR4 (Kyowa Hakko
Kogyo, Tokyo, Japan).19 In a preliminary study, both anti-
CXCR3 and -CCR4 antibodies gave positive staining in
synovial tissues from patients with rheumatoid arthritis
and skin biopsy specimens from patients with atopic
dermatitis. Reactivity of these antibodies was similar/dl) LDH (u/l) %VC (%) PaO2 (Torr) Ly (%)
286 57.2 65.2 15
558 83 66.5 8
628 62.1 42 20
288 101 78.8 5
359 94 64.4 2
433 96 71.9
554 97.4 80 21
381 93.3 91.9 0
600 138 62.7 29
59
600 103 79.4 13
genase, Ly; %lymphocytes in bronchoalveolar lavage fluids.
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T. Yoshinouchi et al.1260between formalin-fixed, paraffin embedded cell blocks and
flow cytometry specimens of peripheral blood mononuclear
cells. Immunoabsorption with CCR4 antigen resulted in
negative stains of those specimens.17
Quantitative assessment of CXCR3+ and CCR4+
lymphocytes
The percentage of infiltrating mononuclear cells within
fibrosing areas staining positively in each case with the anti-
CXCR3 and -CCR4 antibodies was quantified separately. In
each case, 20 random fibrosing areas in high power fields
(HPF, magnification  400) were selected and identified on
each of the sections stained with anti-CXCR3 and -CCR4
antibodies.
Differences between groups were analyzed using the
unpaired t-test. Probability values of Po0.05 were accepted
as significant.
Results
All CXCR3+ cells could be considered morphologically as
lymphocytes. CCR4+ cells were almost lymphocytes, but
CCR4 staining was also positive in some histiocytes and
alveolar macrophages. In normal lung tissues, few CXCR3+
cells were observed, but CCR4 staining was negative. The
results of immunostaining of CXCR3 and CCR4 in fibrosing
areas were showed in Table 2. In patients with NSIP, the
extensively diffuse infiltration of CXCR3+ lymphocytes wasTable 2 The distribution of CXCR3, CCR4-positive cells in fibro
Patient Diagnosis Age (yr) Sex CXCR3 +cell CXCR3
CCR4(%
1 NSIP/C 74 M 313 99.4
2 NSIP/C 66 F 395 97.1
3 NSIP/C 67 F 545 98.9
4 NSIP/C 69 M 274 98.9
5 NSIP/C 73 M 43 95.6
6 NSIP/C 74 M 220 87.6
7 NSIP/C 62 M 285 96
8 NSIP/F 60 M 173 98.9
9 NSIP/F 52 M 347 95.6
10 NSIP/F 67 M 321 97.3
11 NSIP/F 76 M 22 78.6
12 NSIP/F 74 M 195 94.2
13 IPF 73 M 34 53.1
14 IPF 61 M 63 43.4
15 IPF 58 M 29 36.3
16 IPF 67 M 48 64.9
17 IPF 67 M 47 53.4
18 IPF 50 M 64 42.4
19 IPF 62 M 71 49
20 IPF 74 M 97 56.7
21 IPF 67 M 122 51.5
22 IPF 52 M 74 61.7
NSIP/C; cellular NSIP, NSIP/F; fibrosingNSIP, IPF; idiopathic pulmonardetected in areas of lymphoid follicles/aggregates, and the
infiltration of CCR4+ lymphocytes was less than that of
CXCR3+ lymphocytes in number. The infiltration of CCR4+
lymphocytes was also less than that of CXCR3+ lymphocytes
in fibrosing areas of NSIP patients in number (Fig. 1A,B).
Some patients showed diffuse infiltration of CXCR3+ lym-
phoid along the thin alveolar structure. In patients with IPF,
the distribution of CXCR3+ or CCR4+ lymphocytes in areas of
lymphoid aggregates and in fibrosing areas was basically
similar to that in NSIP patients. CXCR3+ lymphocytes were
overnumbered than CCR4+ lymphocytes in areas of lymphoid
aggregates, but the difference between the distribution of
CXCR3+ or CCR4+ lymphocytes was generally subtle in
fibrosing areas (Fig. 2A and B), as we previously described.17
The number of CXCR3+ lymphocytes of NSIP patients was
significantly greater than that of IPF patients (261.17145.1
vs. 64.9727.0, Po0.01). On the other hand, the number of
CCR4+ lymphocytes of NSIP patients was significantly lower
than that of IPF (9.578.3 vs.62.6726.9, po0.01) (Fig. 3).
The CXCR3 to CCR4 ratio of NSIP patients was significantly
greater than that of IPF patients (47.9745.9 vs. 1.1170.40,
Po0.01) (Fig. 4). These results suggest that a Th1 pattern of
chemokine receptor expression predominates in the lung
interstitium of patients with NSIP but, in IPF patients, CCR4
might be relatively predominant, in contrast to the finding
in NSIP patients.
In cellular NSIP patients, the number of CXCR3+ lympho-
cytes (296.47142.7) and CXCR3/CCR4 ratio (58.8749.3)
were significantly greater (Po0.01, Po0.01) and the
number of CCR4+ lymphocytes (9.8679.52) was significantlysing areas of idiopathic NSIP and IPF.
/CXCR3+
)
CCR4+cell CCR4/CXCR3+
CCR4(%)
CXCR3/CCR4ratio
2 0.6 157
12 2.9 32.9
7 1.3 77.9
3 1.1 91.3
2 4.4 21.5
31 2.4 7.1
12 4 23.8
2 1.1 86.5
16 4.4 21.7
9 2..7 35.7
6 21.4 3.67
12 5.8 16.3
30 46.9 1.13
82 56.6 0.77
51 63.7 0.57
26 35.1 1.85
41 46.6 1.15
87 57.6 0.73
74 51 0.96
74 43.3 1.31
115 48.5 1.06
46 38.3 1.61
y fibrosis.
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Figure 1 Immunohistochemical staining with anti-CXCR3 and -
CCR4 antibodies in fibrosing areas of idiopathic NSIP. CXCR3+
lymphocytes (A) were more densely infiltrated than CCR4+
lymphocytes (B) (Original magnification  200).
Figure 2 Immunohistochemical staining with anti-CXCR3 and -
CCR4 antibodies in fibrosing areas of IPF. CCR4+ lymphocytes (B)
were more densely infiltrated than CXCR3+ lymphocytes (A)
(Original magnification  200).
CXCR3 and CCR4 in NSIP 1261lower than those in IPF patients (Po0.01). In fibrosing NSIP
patients, CXCR3/CCR4 ratio (32.8728.8) were significantly
greater and the number of CCR4+ lymphocytes (9.074.82)
was significantly lower than those in IPF patients (Po0.01,
Po0.01). The differences of CXCR3+ or CCR4+ lymphocyte
counts and of CXCR3/CCR4 ratio between cellular and
fibrosing NSIP were not significant (Figs. 3 and 4).
There was no correlation between the number of CXCR3+,
CCR4+ lymphocytes and/or CXCR3/CCR4 ratio, and the
clinical stage of NSIP patients.Discussion
Our findings provide the first evidence that infiltrating
lymphocytes predominantly express CXCR3 rather than CCR4
in lung parenchyma in patients with NSIP, in contrast to
those with IPF, showing relative CCR4 predominance.
Th1 cytokines include interleukin (IL)-18, IL-12, IFN-
gamma and IL-2, and Th2 cytokines are IL-4, IL-5, IL-10
and IL-13. The functions of Th1 and Th2 cytokines are
different, and an imbalance in the expression of Th1 and Th2
cytokines is important in different immunopathological
responses. Several studies have investigated the association
between the Th1/Th2 balance and the expression ofchemokine receptors.10,11 Previously, Th1-selective chemo-
kine receptors were reported to include CXCR3, CCR2, and
CCR5. However, Th1-associated chemokine receptors other
than CXCR3 show little or no preference for Th1 cells except
when these chemokines are coexpressed with CXCR3.12
Activated Th1 cells expressed CXCR3 at high levels, whereas
Th2 cells rarely express CXCR3.10–12 Recent studies have also
reported that CXCR3 is associated with ‘‘Th1 diseases’’ such
as rheumatoid arthritis and multiple sclerosis.11,20 Thus, the
expression of CXCR3 on infiltrated lymphocytes may reflect
local production of IFN-gamma and mean local Th1-
dominant immune response. On the other hand, Th2-
associated chemokine receptors, CCR3, CCR4, CCR8, and
CRTH2 have been described to play a central role in allergic
inflammation. CCR3 and CRTH2 are considerably expressed
on basophils, eosinophils and mast cells. Furthermore CCR3
CCR4 and CCR8 are detected among cells that have
differentiated from naive CD4+ T cells to Th2 and in the
Th2 cell line.10,21 In atopic asthmatics, virtually all the
infiltrating T cells in bronchial mucosa express IL-4 and
CCR4, but not CCR3 after allergen challenge. CCR8 was
expressed, after allergen challenge, in approximately 28% of
the CCR4/IL-4 double positive airway T cells.22 However,
CCR4 is also expressed by a small group of helper T cell
subsets other than Th2 cells, Kim et al.12 pointed out that a
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Figure 3 Numbers of CXCR3+ lymphocytes and CCR4+ lymphocytes per twenty random high power fields (magnification  400) in
fibrosing areas of cellular NSIP, fibrosing NSIP and IPF.
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Figure 4 CXCR3/CCR4 ratio in fibrosing areas of cellular NSIP,
fibrosing NSIP and IPF.
T. Yoshinouchi et al.1262strong and specific correlation with Th1 and Th2 subsets
requires simultaneous evaluation of both receptors:
CXCR3+CCR4– and CCR4+CXCR3– because of the exis-
tence of a CXCR3+CCR4+ (double positive) memory CD4
population.
There are some comparative studies of chemokine
receptor expression in airway diseases or diffuse lung
diseases reporting about CXCR3 and CCR4 expressions. T
cells in the bronchial mucosa of chronic obstructive
pulmonary disease patients predominantly express IFN-
gamma and CXCR3 but do not express IL-4 and CCR4.22 In
sarcoidosis, a disease characterized by a typical cell-
mediated Th1-type inflammatory response,23 lung T cells
express IFN-gamma and CXCR3 but not IL-4 and CCR4.21,24 In
IIP, Wallace has observed that the presence of IL-4 and IL-5predominated over the expression of INF-gamma in lung
tissue of patients with cryptogenic fibrosing alveolitis.25
Several studies have demonstrated the presence of CC
chemokines (MIP-1/CCL3,MCP-1/CCL2) in human interstitial
lung disease26 and Keane et al.27,28 have reported that lung
tissue from patients with IPF has markedly increased
angiogenic CXC chemokines and that angiogenesis supports
fibroplasia and deposition of extracellular matrix in
pulmonary fibrosis. Antoniou et al.29 has described that
type 2 pattern of cytokines is predominant in IPF and that
the cytokine network involves in the pathogenesis of IPF
such as cytokines, chemokines and growth factors. Our study
demonstrated that Th2 type might be also predominant in
the lung of patients with IPF. Therefore, in IPF, Th2-type
cytokine network may release and activate a number of
cytokines/growth factors inducing fibroblast migration/
proliferation and phenotype change to myofibroblasts.
None of the previous studies have investigated the Th1/
Th2 balance in NSIP patients. Our results demonstrate that
the distribution of CXCR3+ or CCR4+ cells is different
between NSIP and IPF. It is suggested that Th1 is predomi-
nant in the lung of NSIP. Dixon et al.30 reported that a
murine model of Th1 cell-induced lung injury in which
adoptive transfer of alloreactive Th1 cells produces pul-
monary inflammation characterized by mononuclear cell
vasculitis, alveolitis and interstitial pneumonitis. We re-
ported that many S-100 DCs were observed in all cases of
NSIP, and CD8+ or CD4+ lymphocytes were infiltrated
diffusely around S-100 DCs, and speculated that DC and T
cell-mediated immune mechanisms may play a role in the
development and perpetuation of NSIP.6 It has been
described that there are at least two different pathogenic
routes for developing pulmonary fibrosis, the inflammatory
pathway represented by almost all non-IPF and the
epithelial pathway represented by IPF.29,31 Therefore, we
speculate that in patients with NSIP, an unknown antigen
ARTICLE IN PRESS
CXCR3 and CCR4 in NSIP 1263activates Th1 cells, making local microenvironment in which
type 1 cytokines such as IFN-gamma are predominant, and
the cytokine network which is different from that in IPF
involves in the pathogenesis of NSIP. If the mechanisms
involved in the above recruitment and activation of
inflammatory cells in the lung and that causing the Th1/
Th2 imbalance are further clarified in the future, effective
agents for NSIP may be developed.
Travis et al.2 investigated the prognosis, and classified
NSIP patients into the cellular and fibrosing patterns. The
fibrosing NSIP shows a poorer prognosis than the cellular
NSIP, and the grade of fibrosis in lung biopsy specimens may
be a prognostic factor for NSIP. We could not find any
significant differences in the appearance of CXCR3+, CCR4+
lymphocytes, or CXCR3/CCR4 ratio between cellular and
fibrosing NSIP in this small case control study, and these
results were not conclusive. Furthermore, it is sometimes
difficult to differentiate IPF from fibrosing NSIP. The results
of this study regarding chemokine receptors may be a key to
the immunohistological differentiation between fibrosing
NSIP and IPF. In the future, this issue should be investigated
in a larger number of patients.
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